ERBB2 and breast cancer: [63] showed that sertraline reduced the viability of AU565 (HER2‐positive breast cancer) cells by downregulating cyclin D1 and upregulating CDK inhibitors p21 and p27, resulting in G1/S cell cycle arrest and caspase‐3‐mediated apoptosis.